semaglutide cardiovascular outcomes study 2025 news and in Patients with Type 2 Diabetes Semaglutide 2.4 mg delivered a

Despite this, there are growing concerns over its serious side effects, including blood clots, DVTs, and pulmonary embolisms

That is quite staggering, Harpreet Singh Bajaj, MD, one of the studys authors, said

GLP-1 probiotics represent an emerging category of dietary supplements marketed to support metabolic health by potentially influencing glucagon-like peptide-1 (GLP-1) production in the gut

The process is more internal-based

Patients with liver disease should follow guidance from the American Association for the Study of Liver Diseases: those with cirrhosis or advanced liver disease should abstain from alcohol completely, while those with milder forms of liver disease, including hepatic steatosis (fatty liver) or early hepatitis, should discuss safe limits with their healthcare provider